NEW TREATMENTS FOR PHELAN-MCDERMID SYNDROME
A Familyâ€™s Story . BY ALISON DALTON
PHOTOGRAPHY BY ANDREW LICHTENSTEIN
Phelan-McDermid Syndrome is a genetically linked form of autism with symptoms that are frequently severe, low muscle tone, motor delays, insomnia, and epilepsy.
The Seaver Autism Center at Mount Sinai, which con-
ducts both fundamental laboratory research and clinical treatment, is currently investigating the effects of two drugs, IGF-1 and oxytocin, on patients with Phelan-McDermid Syndrome. Marc and Chardell Buchanan moved their family from Utah to New York so that their son, Ben, could participate in the treatment trials.
This is their story.
MOUNT SINAI SCIENCE & MEDICINE / FALL 2016
including intellectual disability, delayed or absent speech,
9/3/16 12:16 PM